open access

Vol 16, No 5 (2012)
REVIEV
Published online: 2013-03-21
Get Citation

Therapeutical inertia in hypertension treatment

Katarzyna Pawlaczyk-Gabriel, Ewa Miciak-Ławicka, Andrzej Tykarski
Nadciśnienie tętnicze 2012;16(5):321-329.

open access

Vol 16, No 5 (2012)
REVIEV
Published online: 2013-03-21

Abstract

Arterial hypertension is a civilization disease. According to
the recent studies it concerns about 9.5 million people in
Poland, and among people throughout the world this
number is estimated to be more than a billion. Prevalence
of hypertension is associated with an increased risk of complications,
such as heart disease, stroke, chronic kidney
disease or ophthalmic complications. The treatment of hypertension
absorbs a serious part of the appropriations intended
for health protection in different countries. However,
despite the continued progress taking place in the
diagnosis and treatment of hypertension and increasing
the sums that are spent by governments and the funds of
the health protection, treatment results are unsatisfactory.
The WOBASZ study evaluated several parameters related
to the occurrence and treatment of arterial hypertension in
all provinces in Poland determined that the percentage of
patients with well-controlled hypertension was 10% in men
and 16% in women, while according to NATPOL 2011
survey effectiveness of blood pressure control among hypertensive
patients in Poland is 26%.
One of the reasons of low blood pressure control is phenomenon,
called therapeutical inertia (TI). It is defined
as the treating physician failure in achieving the goals of
management, related to the lack of action to increase the
dose of already used medication and/or to add another
preparation. TI concerns not only the treatment of hypertension,
but also dyslipidemia or diabetes treatment.
The goals to be achieved in the treatment of these diseases have been exactly defined and effective treatment is
widely available.

Abstract

Arterial hypertension is a civilization disease. According to
the recent studies it concerns about 9.5 million people in
Poland, and among people throughout the world this
number is estimated to be more than a billion. Prevalence
of hypertension is associated with an increased risk of complications,
such as heart disease, stroke, chronic kidney
disease or ophthalmic complications. The treatment of hypertension
absorbs a serious part of the appropriations intended
for health protection in different countries. However,
despite the continued progress taking place in the
diagnosis and treatment of hypertension and increasing
the sums that are spent by governments and the funds of
the health protection, treatment results are unsatisfactory.
The WOBASZ study evaluated several parameters related
to the occurrence and treatment of arterial hypertension in
all provinces in Poland determined that the percentage of
patients with well-controlled hypertension was 10% in men
and 16% in women, while according to NATPOL 2011
survey effectiveness of blood pressure control among hypertensive
patients in Poland is 26%.
One of the reasons of low blood pressure control is phenomenon,
called therapeutical inertia (TI). It is defined
as the treating physician failure in achieving the goals of
management, related to the lack of action to increase the
dose of already used medication and/or to add another
preparation. TI concerns not only the treatment of hypertension,
but also dyslipidemia or diabetes treatment.
The goals to be achieved in the treatment of these diseases have been exactly defined and effective treatment is
widely available.
Get Citation

Keywords

arterial hypertension treatment, therapeutical inertia, treatment intensification

About this article
Title

Therapeutical inertia in hypertension treatment

Journal

Arterial Hypertension

Issue

Vol 16, No 5 (2012)

Pages

321-329

Published online

2013-03-21

Bibliographic record

Nadciśnienie tętnicze 2012;16(5):321-329.

Keywords

arterial hypertension treatment
therapeutical inertia
treatment intensification

Authors

Katarzyna Pawlaczyk-Gabriel
Ewa Miciak-Ławicka
Andrzej Tykarski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl